Adenovirus-mediated transfer of FRNK augments drug-induced cytotoxicity in cultured SCCHN cells

Anticancer Research

Volumn 25, Issue 6 B, 2005, Pages 4349-4356

  Kornberg, Lori J ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

5 Fluorouracil; Apoptosis; Etoposide; FAK; FRNK; Paclitaxel; SCCHN cells

Indexed keywords

ADENOVIRUS VECTOR; ANTINEOPLASTIC AGENT; CISPLATIN; CYTOTOXIC AGENT; ETOPOSIDE; FLUOROURACIL; FOCAL ADHESION KINASE; FOCAL ADHESION KINASE RELATED NONKINASE; PACLITAXEL; UNCLASSIFIED DRUG;

APOPTOSIS; AUTOPHOSPHORYLATION; CELL CYCLE; CELL INVASION; CELL MIGRATION; CELL SURVIVAL; CELL TRANSFORMATION; CELL VIABILITY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFICACY; ENZYME INHIBITION; GENE OVEREXPRESSION; GENE TARGETING; GENE TRANSFER; GENETIC TRANSFECTION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT;

ADENOVIRIDAE; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; COMBINED MODALITY THERAPY; ETOPOSIDE; FLUOROURACIL; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GENE THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; PACLITAXEL; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; TRANSFECTION;

EID: 27944510086     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (33)

1. Kanner SB, Reynolds AB, Vines RR and Parsons JT: Monoclonal antibodies to individual tyrosine phosphorylated protein substrates of oncogene-encoded tyrosine kinases. Proc Natl Acad Sci USA 87: 3328-3332, 1992.
2. Schaller MD, Borgman CA, Cob BS, Vines RR, Reynold ABs and Parsons JT: Pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc Natl Acad Sci (USA) 59: 5192-5196, 1992.
3. Gabarra-Nieko V, Schaller MD and Dunty JM: FAK regulates biological processes important for the pathogenesis of cancer. Cancer Metastasis Rev 22: 359-374, 2003.
4. Hildebrand JD, Schaller MD and Parsons JT: Identification of sequences required for the efficient localization of the focal adhesion kinase, pp125FAK, to cellular focal adhesions. J Cell Biol 123: 993-1005, 1993.
5. Schaller MD, Borgman CA and Parsons JT: Autonomous expression of a non catalytic domain of focal adhesion-associated protein tyrosine kinase pp125FAK. Mol Cell Biol 13: 785-791, 1993.
6. Richardson A and Parsons JT: A mechanism for regulation of the adhesion-associated protein tyrosine kinase pp125FAK. Nature 380: 538-540, 1996.
7. Kornberg LJ: Focal adhesion kinase expression in oral cancers. Head Neck 20: 634-639, 1998.
8. Owens LV, Xu LH, Craven RJ, Dent GA, Weiner TM, Kornberg LJ, Lui ET and Cance WG: Overexpression of the focal adhesion kinase (p125fak) in invasive human tumors. Cancer Res 55: 2752-2755, 1995.
9. Judson PL, He X, Cance WG and Van LEL: Over expression of focal adhesion kinase, a protein tyrosine kinase, in ovarian carcinoma. Cancer 86: 1551-1556, 1999.
10. Tremblay L, Hauck W, Aprikian AG, Begin LR, Chapelaine A and Chevalier S: Focal adhesion kinase (pp125FAK) expression, activation and association with paxillin and p50csk in human metastatic prostate carcinoma. Int J Cancer 68: 164-171, 1996.
11. Hecker TP, Grammer JR, Gillespie GY and Stewert J Jr: Focal adhesion kinase enhances signaling through the Shc/extracellular signal-regulated kinase pathway in anaplastic astrocytoma tumor biopsy samples. Cancer Res 62: 2699-707, 2002.
12. Cance WG, Harris JE, Iacocca MV, Roche E, Yang X, Chang J, Simpkins S and Xu L: Imunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. Clin Cancer Res 6: 2417-2423, 2000.
13. Kornberg LJ and Fleigel J: The effects of inducible overexpression of FAK-related non-kinase (FRNK) on a transformed epithelial cell line. Anticancer Res 23: 91-97, 2003.
14. Allen S, Sotos J, Sylte MJ and Czuprynski CJ: Use of Hoechst 33342 staining to detect apoptotic changes in bovine mononuclear phagocytes infected with Mycobacterium avium subsp. Paratuberculosi. Clin Diagn Lab Immunol 8: 460-464, 2001.
15. Ilic D, Almeida EAC, Schlaepfer DD, Dazin P, Aizawa S and Damsky CH: Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis. J Cell Biol 143: 547-560, 1998.
16. Pergolizzi S, Adamo V, Ferraro G, Sergi C, Santacaterina A, Romeo A, Zanghi C, Rosswello R and Settineri N: Induction chemotherapy to weekly paclitaxel concurrent with curative radiotherapy in stage IV (M0) unresectable head and neck squamous cell carcinoma: a dose escalation study. J Chemother 16: 201-205, 2004.
17. Khafif A, Canfield VA, Syzek EJ and Medina JE: Results of phase I-II trial of concomitant hyperfractionated radiation and oral etoposide (VP-16) in patients with unresectable squamous cell carcinoma of the head and neck. Am J Otolaryngol 24: 1-5, 2003.
18. Miyazaki T, Kato H, Nakajima M et al: FAK overexpression is correlated with tumor invasiveness and lymph node metastasis in esophageal squamous cell carcinoma. Br J Cancer 89: 140-145, 2003.
19. Yu F, Dong Y, Jiao J, Zhang H, Li X and Liang Z: Expression of focal adhesion kinase in laryngeal carcinoma. Lin Chuang Er Bi Yan Hou Ke Za Zhi 18: 149-151, 2004.
20. Fujii T, Koshikawa K, Nomoto S et al: Focal adhesion kinase is overexpressed in hepatocellular carcinoma and can be served as an independent prognostic indicator. J Hepatol 41: 104-111, 2004.
21. Recher C, Ysebaert L, Beyne-Rauzy O et al: Expression of focal adhesion kinase in acute myeloid leukemia is associated with enhanced blast migration, increased cellularity, and poor prognosis. Cancer Res 64: 3191-3197, 2004.
22. Theocharis SE, Kouraklis GP, Kakisis JD et al: Focal adhesion kinase expression is not a prognostic predictor in colon adenocarcinoma patients. Eur J Surg Oncol 29: 571-574, 2004.
23. McLean GW, Komiyama NH, Serrels B, Asano H, Reynolds L, Conti F et al: Specific deletion of focal adhesion kinase suppresses tumor formation and blocks malignant progression. Genes Develop 18: 2998-3003, 2004.
24. Xu LH, Yang X, Craven RJ and Cance WG: The COOH-terminal domain of the focal adhesion kinase induces loss of adhesion and cell death in human tumor cells. Cell Growth Diff 9: 999-10005, 1998.
25. Slack JK, Adams RB, Rovin JD et al: Alterations in the focal adhesion kinase/Src signal transduction pathway correlate with increased migratory capacity of prostate carcinoma cells. Oncogene 20: 1152-1163, 2001.
26. Jones G, Machado J, Tolnay M et al: PTEN-independent induction of caspase-mediated cell death and reduced invasion by the focal adhesion targeting domain (FAT) in human astrocytic brain tumors, which highly express focal adhesion kinase (FAK). Cancer Res 61: 5688-5691, 2001.
27. Shibata K, Kikkawa F, Nawa A et al: Both focal adhesion kinase and c-ras are required for the enhanced matrix metalloproteinase 9 secretion by fibronectin in ovarian cancer cells. Cancer Res 58: 900-903, 1998.
28. Duxbury MS, Ito H, Benoit E, Zinner MJ, Ashley SW and Whang EE: RNA interference targeting focal adhesion kinase enhances pancreatic adenocarcinoma gemcitabine chemosensitivity. Biochem Biophys Res Commun 311: 786-792, 2003.
29. Van Water B, Houtepen F, Huigsloot M et al: Suppression of chemically induced apoptosis but not necrosis of renal proximal tubular epithelial (LLC-PK1) cells by focal adhesion kinase (FAK). J Biol Chem 276: 36183-36193, 2001.
30. Satoh TH, Surmacz TA, Nyormoi O and Whitacre CM: Inhibition of focal adhesion kinase by antisense oligonucleotides enhances the sensitivity of breast cancer cells to camptothecins. Biocell 27: 47-55, 2003.
31. Xu L-H, Yang X, Bradham CA, Brenner DA, Baldwin AS, Craven RJ and Cance WG: The focal adhesion kinase suppresses transformation-associated, anchorage-independent apoptosis in human breast cancer cells. J Biol Chem 275: 30597-306, 2000.
32. Min BM, Baek JH, Shin KH, Gujuluva CN, Cherrick HM and Park NH: Inactivation of the p53 gene by either mutation or HPV infection is extremely frequent in human oral squamous cell carcinoma cell lines. Eur J Cancer B Oral Oncol 5: 338-345, 1994.
33. Heiliez C, Baricault L, Barboule N and Valett A: Paclitaxel increases p21 synthesis and accumulation of its AKT-phosphorylated form in the cytoplasm of cancer cells. Oncogene 22: 3260-3268, 2003.